About Attomarker
Attomarker is a company based in Exeter (United Kingdom) founded in 2008 by Andrew Shaw. Attomarker offers products and services including COVID Antibody Spectrum Test, Human Infection Spectrum Test, Liver Spectrum Test, and Fertility Spectrum Test. Attomarker operates in a competitive market with competitors including EKF, LumiraDx, SpinChip, LightDeck Diagnostics and EDX Medical Group, among others.
- Headquarter Exeter, United Kingdom
- Founders Andrew Shaw
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Attomarker Limited
- Date of Incorporation 01 Apr, 2008
- Jurisdiction EXETER, DEVON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Attomarker
Attomarker offers a comprehensive portfolio of products and services, including COVID Antibody Spectrum Test, Human Infection Spectrum Test, Liver Spectrum Test, and Fertility Spectrum Test.
Test for detecting COVID antibodies and immunity levels quickly.
Assesses various human infections for early detection and treatment.
Evaluates liver health through rapid biomarker analysis.
Analyzes fertility indicators for reproductive health monitoring.
People of Attomarker
Unlock access to complete
Unlock access to complete
Funding Insights of Attomarker
Investors in Attomarker
Attomarker has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Innova Medical Group and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Develops rapid diagnostic tests and medical devices for worldwide health needs.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Attomarker
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Attomarker
Investment portfolio details for Attomarker
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Attomarker
Detailed financials for Attomarker
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Attomarker Comparisons
Peer comparison for Attomarker
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Attomarker
Attomarker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, LumiraDx, SpinChip, LightDeck Diagnostics and EDX Medical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
Cloud based diagnostics platform for point of care diagnosing
|
|
| Locked | Locked | Locked |
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| Locked | Locked | Locked |
Medical diagnostics solutions are researched by the laboratory.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
Detailed competitors of Attomarker
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Attomarker
Complete news archive for Attomarker
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Attomarker
Attomarker was founded in 2008 and raised its 1st funding round 7 years after it was founded.
Attomarker is headquartered in Exeter, United Kingdom. It is registered at Exeter, Devon, United Kingdom.
Andrew Shaw is the current CEO of Attomarker. They have also founded this company.
Attomarker was founded in 2008 in Exeter, United Kingdom, and operates in the health diagnostics sector. An online platform is offered for purchasing COVID-19 test kits to detect biomarkers, with an accompanying app used to view test results. A blood-testing device has been developed for healthcare settings to analyze various blood biomarkers, which can be connected to a smartphone app for data management.
Attomarker offers COVID Antibody Spectrum Test, Human Infection Spectrum Test, Liver Spectrum Test, and Fertility Spectrum Test.
Attomarker has 3 investors. Key investors include European Union, Innova Medical Group, and EIC Fund.